Akcea and Ionis to present new data for TEGSEDI and AKCEA-TTR-LRx at two upcoming medical meetings

Multiple presentations on the long-term efficacy and safety of TEGSEDI® (inotersen) in patients with polyneuropathy caused by hATTR Amyloidosis

The release as fetched from its publisher. ionis.com ↗